NRAS Polyclonal antibody 10724-1-AP proteintech

$149.00
In stock
SKU
10724-1-AP
Catalog No.SizePrice (USD)
10724-1-AP-20UL20 μL$149.00
10724-1-AP-150UL150 μL$449.00
Catalog Number10724-1-AP
SynonymsHRAS1, EC:3.6.5.2, GTPase NRas, N ras, NRAS1
HostRabbit
Reactivityhuman, mouse, rat
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF/ICC, FC (Intra), IP, ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inA431 cells, C6 cells, NIH/3T3 cells, Jurkat cells, A549 cells, HEK-293 cells, MCF-7 cells
Tested Applications — Positive IP detected inHEK-293 cells
Tested Applications — Positive IHC detected inhuman pancreas tissue, human testis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Tested Applications — Positive IF/ICC detected inHeLa cells
Tested Applications — Positive FC (Intra) detected inHepG2 cells
Recommended Dilutions — Western Blot (WB)WB : 1:500-1:2000
Recommended Dilutions — Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:50-1:500
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Recommended Dilutions — Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
Positive WB detected inA431 cells, C6 cells, NIH/3T3 cells, Jurkat cells, A549 cells, HEK-293 cells, MCF-7 cells
Positive IP detected inHEK-293 cells
Positive IHC detected inhuman pancreas tissue, human testis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHeLa cells
Positive FC (Intra) detected inHepG2 cells
Western Blot (WB)WB : 1:500-1:2000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
Tested Reactivityhuman, mouse, rat
Cited Reactivityhuman, mouse, rat
ClassPolyclonal
TypeAntibody
ImmunogenCatNo: Ag1081 Product name: Recombinant human NRAS protein Source: e coli. -derived, PGEX-4T Tag: GST Domain: 1-189 aa of BC005219 Sequence: MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNSKSFADINLYREQIKRVKDSDDVPMVLVGNKCDLPTRTVDTKQAHELAKSYGIPFIETSAKTRQGVEDAFYTLVREIRQYRMKKLNSSDDGTQGCMGLPCVVM Predict reactive species
Full Nameneuroblastoma RAS viral (v-ras) oncogene homolog
Calculated Molecular Weight21 kDa
Observed Molecular Weight21 kDa
GenBank Accession NumberBC005219
Gene SymbolNRAS
Gene ID (NCBI)4893
RRIDAB_2154209
ConjugateUnconjugated
Purification MethodAntigen affinity purification
UNIPROT IDP01111
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
FC protocol for NRAS antibody 10724-1-APDownload protocol
IF protocol for NRAS antibody 10724-1-APDownload protocol
IHC protocol for NRAS antibody 10724-1-APDownload protocol
IP protocol for NRAS antibody 10724-1-APDownload protocol
WB protocol for NRAS antibody 10724-1-APDownload protocol
mouseWB Cell A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence Authors - Yujing Cheng View Article
humanWB Cancer Res Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma. Authors - Patience Odeniyide View Article
RAFAEL (Verified Customer) (03-18-2026)The antibody is not entirely specific, as it recognizes other Ras isoforms such as KRAS Applications: Western Blot Primary Antibody Dilution: 1:1000 Cell Tissue Type: Hela cells NRAS Antibody Western Blot validation (1:1000 dilution) in Hela cells (Cat no:10724-1-AP)
Brandon (Verified Customer) (11-27-2018)Worked excellent on mouse tissue from inducible tumor model! Applications: Immunohistochemistry, Primary Antibody Dilution: 1:100 Cell Tissue Type: Mouse Tumor Tissue
Citations50
DilutionsWB : 1:500-1:2000 IP : 0.5-4.0 ug for IP and 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate for WB IHC : 1:50-1:500 IF/ICC : 1:200-1:800 FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
IsotypeIgG
ClonalityPolyclonal
Clone Number-
ConjugationUnconjugated

Neuroblastoma rat sarcoma viral oncogene homolog (NRAS) was originally identified as the third RAS family member following KRAS and HRAS in human neuroblastoma and fibrosarcoma cell lines (PMID: 6572964). Akin to KRAS, NRAS encodes small GTP enzymes which regulate cell cycle, proliferation, maturation and differentiation by transducing signals from membrane-localized receptor tyrosine kinases to the nucleus. The mutation of RAS gene family occurs in nearly 30% of human cancers (PMID: 12509763). NRAS plays an important role in EGFR mediating RAS/RAF/MEK/ERK and PI3K/AKT/mTOR signaling pathways (PMID: 17297468). The mutation of NRAS leads to continuous activation of Ras-GTP, which promotes tumorigenesis and metastasis. It has been proved that NRAS acts as a negative prognosis predictor in numerous somatic malignancies, such as melanoma, colorectal cancer and hepatocellular carcinoma (PMID: 30685691, PMID: 30484984). Besides, NRAS, as a proto-oncogene, is also proved to be associated with tumor immune microenvironment (TIM) both in vivo and in vitro. NRAS GTPase is related to T-cell proliferation and immune response (PMID: 34746975). NRAS, also named as N-ras and NRAS1, is neuroblastoma RAS viral (v-ras) oncogene homolog from the mammalian ras gene family and it is a member of the small GTPase superfamily. RAS proteins are involved in signal transduction pathways, and bind GDP/GTP and possess intrinsic GTPase activity. It is mapped on chromosome 1, and it is activated in HL60, a promyelocytic leukemia line. Defects in NRAS are a cause of juvenile myelomonocytic leukemia (JMML). Protocols Product Specific Protocols FC protocol for NRAS antibody 10724-1-AP Download protocol IF protocol for NRAS antibody 10724-1-AP Download protocol IHC protocol for NRAS antibody 10724-1-AP Download protocol IP protocol for NRAS antibody 10724-1-AP Download protocol WB protocol for NRAS antibody 10724-1-AP Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence
    Journal: Cell | Authors: Yujing Cheng | Species: mouse | Application: WB
  2. Nuclear export of R-loop by the DDX1 and XPO1 complex promotes senescence-associated secretory phenotype and inflammaging
    Journal: Nat Aging | Authors: Xue Hao | Species: human | Application: IF
  3. RNA helicase DDX5 enables STAT1 mRNA translation and interferon signalling in hepatitis B virus replicating hepatocytes.
    Journal: Gut | Authors: Jiazeng Sun | Species: human | Application: WB
  4. ADAR1 downregulation by autophagy drives senescence independently of RNA editing by enhancing p16INK4a levels.
    Journal: Nat Cell Biol | Authors: Xue Hao | Species: human | Application: IF
  5. Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.
    Journal: Cancer Res | Authors: Mandana Kamgar | Species: human | Application: WB
  6. Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma.
    Journal: Cancer Res | Authors: Patience Odeniyide | Species: human | Application: WB
  7. Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma.
    Journal: Cancer Res | Authors: Patience Odeniyide | Species: human | Application: WB
  8. KRAS regulation by small non-coding RNAs and SNARE proteins.
    Journal: Nat Commun | Authors: Yonglu Che | Species: human | Application: IF
  9. Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma
    Journal: Nat Commun | Authors: Perla Pucci | Species: human | Application: WB
  10. Hepatocyte growth factor derived from senescent cells attenuates cell competition-induced apical elimination of oncogenic cells
    Journal: Nat Commun | Authors: Nanase Igarashi | Species: mouse | Application: IHC
  11. Mevalonate pathway rewiring driven by enhancer remodelling confers resistance to KRAS inhibitors in colorectal cancer.
    Journal: Nat Commun | Authors: Yaoyu Guo | Species: human | Application: WB
  12. Near-Infrared Phototheranostic Iron Pyrite Nanocrystals Simultaneously Induce Dual Cell Death Pathways via Enhanced Fenton Reactions in Triple-Negative Breast Cancer
    Journal: ACS Nano | Authors: Chunhua Zhao | Species: human | Application: WB
  13. A pan-KRAS degrader for the treatment of KRAS-mutant cancers
    Journal: Cell Discov | Authors: Jie Yang | Species: human | Application: WB,IP
  14. Polymeric nanoparticle mediated inhibition of miR-21 with enhanced miR-124 expression for combinatorial glioblastoma therapy.
    Journal: Biomaterials | Authors: Yuanyuan Liu | Species: mouse,human | Application: WB
  15. Manganese-tannic acid immunomodulators potentiate PDGFRβ CAR-T cell function for additive therapy against liver fibrosis.
    Journal: J Control Release | Authors: Xinyu Wang | Species: human | Application: WB
  16. ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma.
    Journal: Cancer Lett | Authors: Shiqiong Xu | Species: human | Application: WB
  17. Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling.
    Journal: Clin Cancer Res | Authors: Chen Liu | Species: human | Application: WB
  18. Epitranscriptic regulation of HRAS by N6-methyladenosine drives tumor progression
    Journal: Proc Natl Acad Sci U S A | Authors: Yongbo Pan | Species: human | Application: WB
  19. Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.
    Journal: Oncogene | Authors: Patience Odeniyide | Species: human | Application: WB,IF
  20. Artemisinin inhibits NRas palmitoylation by targeting the protein acyltransferase ZDHHC6.
    Journal: Cell Chem Biol | Authors: Nan Qiu | Species: human | Application: WB,IF
  21. Targeting Endogenous K-RAS for Degradation through the Affinity-Directed Protein Missile System.
    Journal: Cell Chem Biol | Authors: Sascha Röth | Species: human | Application: WB
  22. Unveiling the role of G-quadruplex structure in promoter region: Regulation of ABCA1 expression in macrophages possibly via NONO protein recruitment
    Journal: Int J Biol Macromol | Authors: Chao-Da Xiao | Species: human | Application: WB
  23. Accumulated sotorasib-bound KRAS(G12C) reactivates the MAPK pathway and drives sotorasib resistance via the DHX9-RAC1-PAK1 axis.
    Journal: Cell Rep | Authors: Gongmin Zhu | Species: human | Application: WB
  24. Suppression of NRAS-mutant melanoma growth with NRAS-targeting Antisense Oligonucleotide treatment reveals therapeutically relevant kinase co-dependencies
    Journal: Commun Med (Lond) | Authors: Valentin Feichtenschlager
  25. Characterizations of G-Quadruplex RNA-Protein Interactions in Living Cells.
    Journal: Anal Chem | Authors: Feng Tang | Species: human | Application: WB
  26. Ionic Liquid-Based Extraction System for In-Depth Analysis of Membrane Protein Complexes.
    Journal: Anal Chem | Authors: Hongwei Chu | Species: human | Application: WB
  27. Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies.
    Journal: Sci Signal | Authors: Andrew M Waters | Species: human | Application: WB
  28. Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation
    Journal: JCI Insight | Authors: Pan-Yu Chen | Species: human | Application: WB
  29. Design, synthesis, and evaluation of novel quindoline derivatives with fork-shaped side chains as RNA G-quadruplex stabilizers for repressing oncogene NRAS translation
    Journal: Eur J Med Chem | Authors: Jia-Wei Sun | Species: human | Application: WB
  30. ALG3 Promotes Peritoneal Metastasis of Ovarian Cancer through Increasing Interaction of α1,3-mannosylated uPAR and ADAM8
    Journal: Cells | Authors: Xinyuan Cui | Species: human | Application: WB
  31. NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth
    Journal: Mol Cancer Res | Authors: Chufan Cai | Species: human | Application: WB
  32. Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular Carcinoma.
    Journal: Front Pharmacol | Authors: Zhong-Kun Xia | Species: human | Application: WB
  33. A First-Class Degrader Candidate Targeting Both KRAS G12D and G12V Mediated by CANDDY Technology Independent of Ubiquitination
    Journal: Molecules | Authors: Etsuko Miyamoto-Sato | Species: mouse | Application: WB
  34. Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression.
    Journal: Oncotarget | Authors: Shanqi Guo | Species: human | Application: WB
  35. Dihydroartemisinin-driven selective anti-lung cancer proliferation by binding to EGFR and inhibition of NRAS signaling pathway-induced DNA damage
    Journal: Sci Rep | Authors: Liu-Gen Li | Species: mouse,human | Application: WB,IHC
  36. Argonaute 2 modulates EGFR-RAS signaling to promote mutant HRAS and NRAS-driven malignancies
    Journal: PNAS Nexus | Authors: Ronald F Siebenaler | Species: mouse,human | Application: WB
  37. Identification of NRAS Downstream Genes with CRISPR Activation Screening
    Journal: Biology (Basel) | Authors: Akiya Tatsumi | Species: human | Application: WB
  38. BRAF Inhibition-Associated Nuclear Remodeling is Linked to Cancer-Associated Fibroblast Activation.
    Journal: Cancer Res Commun | Authors: Jie Wang
  39. The Function and Clinical Significance of TRPV2 in Human Colon Cancer
    Journal: Ann Surg Oncol | Authors: Naosuke Nakamichi
  40. Chlorin e6-mediated sublethal photodynamic therapy modulates biomarkers in a murine lung cancer-derived in vitro cancer-associated fibroblast model.
    Journal: Photochem Photobiol Sci | Authors: Shuntianci Zhang
  41. Aspafilioside B induces G2/M cell cycle arrest and apoptosis by up-regulating H-Ras and N-Ras via ERK and p38 MAPK signaling pathways in human hepatoma HepG2 cells.
    Journal: Mol Carcinog | Authors: Wei Liu | Species: human | Application: WB
  42. microRNA-203 functions as a natural Ras inhibitor in hepatocellular carcinoma
    Journal: Am J Cancer Res | Authors: Jun Guo | Species: mouse,human | Application: WB,IHC
  43. NRAS and SREBF1 identified as mitophagy-associated risk genes for rheumatoid arthritis through interpretable machine learning and experimental validation studies.
    Journal: BMC Rheumatol | Authors: Hongman Li | Species: human, rat | Application: WB,IHC
  44. Comprehensive Analysis of the Tumor Microenvironment and Ferroptosis-Related Genes Predict Prognosis with Ovarian Cancer.
    Journal: Front Genet | Authors: Xiao-Xue Li | Species: human | Application: WB
  45. Enhanced anti-tumor effect of liposomal Fasudil on hepatocellular carcinoma in vitro and in vivo.
    Journal: PLoS One | Authors: Ying Zhao | Species: human | Application: IHC
  46. Immunohistochemical assessment of growth factor signaling molecules: MAPK, Akt, and STAT3 pathways in oral epithelial precursor lesions and squamous cell carcinoma.
    Journal: Odontology | Authors: Kazuki Tashiro | Species: human | Application: IHC
  47. Albiflorin attenuates post-myocardial infarction cardiac fibrosis through inhibiting the RAS-ERK/MAPK signaling pathway.
    Journal: Biochem Biophys Res Commun | Authors: Mei Lv | Species: mouse | Application: WB
  48. Actin-modulated nuclear shape controls adaptive reprogramming in cancer-associated fibroblasts
    Journal: bioRxiv | Authors: Jie Wang | Application: WB
  49. Actin-modulated nuclear shape controls adaptive reprogramming in cancer-associated fibroblasts
    Journal: bioRxiv | Authors: Jie Wang | Application: WB
  50. Overcoming Daraxonrasib Resistance: Allele-Specific Mechanisms Guide Salvage Therapy in Pancreatic Cancer.
    Journal: bioRxiv | Authors: Daniel Dorbin

Reviews

Write Your Own Review
You're reviewing:NRAS Polyclonal antibody 10724-1-AP proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.